• 1
    Bachmann F. Fibrinolytic agents. Fibrinolysis 1995; 9 (suppl 1): 915.
  • 2
    Binder BR. Physiology and pathophysiology of the fibrinolytic system. Fibrinolysis 1995; 9 (suppl 1): 38.
  • 3
    Collen D. Fibrin-selective thrombolytic therapy for acute myocardial infarction. Circulation 1996; 93: 857865.
  • 4
    Spellman MW, Basa LJ, Leonard CK, Chakel JA, O'Connor JV, Wilson S, Van Halbeek H. Carbohydrate structures of human tissue-type plasminogen activator expressed in Chinese hamster ovary cells. J Biol Chem 1989; 264: 1410014111.
  • 5
    Kuiper J, Otter M, Rijken DC, van Berkel THJC. Characterization of the interaction in vivo of tissue-type plasminogen activator with liver cells. J Biol Chem 1988; 263: 1822018224.
  • 6
    Brommer EJ, Derkx FH, Schalekamp MA, Dooijewaard G, van de Klaauw MM. Renal and hepatic handling of endogenous tissue-type plasminogen activator (t-PA) and its inhibitor in man. Thromb Haemost 1988; 59: 404411.
  • 7
    Otter M, Kuiper J, Bos R, Rijken DC, van Berkel THJC. Characterization of the interaction both in vitro and in vivo of tissue-type plasminogen activator (t-PA) with rat liver cells. Biochem J 1992; 284: 545550.
  • 8
    Warshawsky I, Bu G, Schwartz AL. 39-kD protein inhibits tissue-type plasminogen activator clearance in vivo. J Clin Invest 1993; 92: 937944.
  • 9
    Narita M, Bu G, Herz J, Schwartz AL. Two receptor systems are involved in the plasma clearance of tissue-type plasminogen activator (t-PA) in vivo. J Clin Invest 1995; 96: 11641168.
  • 10
    Biessen EAL, van Teijlingen M, Vietsch H, Barrett-Bergshoeff MM, Bijsterbosch MK, Rijken DC, van Berkel THJC, et al. Antagonists of the mannose receptor and the LDL receptor-related protein dramatically delay the clearance of tissue-type plasminogen activator. Circulation 1997; 95: 4652.
  • 11
    Zito RA, Reid PR. Lidocaine kinetics predicted by indocyanine green clearance. N Engl J Med 1987; 298: 11601163.
  • 12
    De Boer A, Kluft C, Kroon JM, Kasper FJ, Schoemaker HC, Pruis J, Breimer DD, et al. Liver blood flow as a major determinant of the clearance of recombinant human tissue-type plasminogen activator. Thromb Haemost 1992; 67: 8387.
  • 13
    De Boer A, Kluft C, Dooijewaard G, Kasper FJ, Kroon JM, Breimer DD, Stiekema JC, et al. Influence of heparin and a low molecular weight heparinoid on specific endogenous and exogenous fibrinolytic factors during rest and exercise. Thromb Haemost 1992; 68: 550555.
  • 14
    Noorman F, Braat EAM, Rijken DC. Degradation of tissue-type plasminogen activator (t-PA) by human monocyte derived macrophages is mediated by the mannose receptor and by the low density lipoprotein-related protein (LRP). Blood 1995; 86: 34213427.
  • 15
    Moestrop SK, Gliemann J, Pallesen G. Distribution of the α2-macroglobulin receptor/low density lipoprotein receptor-related protein in human tissues. Cell Tissue Res 1992; 269: 375382.
  • 16
    Dalen DP Praaning-van, de Leeuw AM, Brouwer A, Knock DL. Rat liver endothelial cells have a greater capacity than Kupffer cells to endocytose N-acetylglucosamine-and mannose-terminated glycoproteins. Hepatology 1987; 7: 672679.
  • 17
    Messner DJ. The mannose receptor and the cation-dependent form of mannose-6-phosphate receptor have overlapping cellular and subcellular distributions in liver. Arch Biochem Biophys 1993; 306: 391401.
  • 18
    Otter M, Zockova P, Kuiper J, van Berkel THJC, Barrett-Bergshoeff MM, Rijken DC. Isolation and characterization of the mannose receptor from human liver potentially involved in the plasma clearance of tissue-type plasminogen activator. Hepatology 1992; 16: 5459.
  • 19
    Biessen EAL, Noorman F, van Teylingen M, Kuiper J, Barrett-Bergshoeff MM, Rijken DC, Bijsterbosch MK, et al. Design of cluster mannosides as high affinity ligands for the human mannose receptor. J Biol Chem 1996; 271: 2802428030.
  • 20
    Herz J, Goldstein JL, Strickland DK, Ho YK, Brown MS. 39-kDa protein modulates binding of ligands to low density lipoprotein receptor-related protein/α2-macroglobulin receptor. J Biol Chem 1991; 266: 2123221238.
  • 21
    Barrett-Bergshoeff MM, Noorman F, Bos R, Rijken DC. Monoclonal antibodies against the human mannose receptor that inhibit the binding of tissue-type plasminogen activator. Thromb Haemost 1997; 77: 718724.
  • 22
    Noorman F, Braat EAM, Barrett-Bergshoeff MM, Barbé E, van Leeuwen A, Lindeman J, Rijken DC. Monoclonal antibodies against the human mannose receptor as a specific marker in flow cytometry and immunohistochemistry for macrophages. J Leukoc Biol 1997; 61: 6372.
  • 23
    Cordell JL, Falini B, Erber WN, Ghosh AK, Abdulaziz Z, McDonald S, Pulford KAF, et al. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal ant-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 1984; 32: 219223.
  • 24
    Nagelkerke JF, Barto KP, van Berkel ThJC. In vivo and in vitro uptake and degradation of acetylated low density lipoprotein by rat liver endothelial, Kupffer and parenchymal cells. J Biol Chem 1983; 258: 1222112227.
  • 25
    Pulford KAF, Rigney KJ, Micklem KJ, Jones M, Stross WP, Gatter KC, Mason DY. KP1: a new monoclonal antibody that detects a monocyte/ macrophage associated antigen in routinely processed tissue sections. J Clin Pathol 1989; 42: 414421.
  • 26
    Ohsumi Y, Hoppe CA, Ogawa T, Lee YC. Enhancement of macromolecular ligand binding by rabbit alveolar macrophages by mannose oligosaccharides and related compounds. Arch Biochem Biophys 1988; 260: 241249.
  • 27
    Robbins JC, Lam MH, Stripp CS, Bugianesi RL, Ponpipom MM, Shen TY. Synthetic glycopeptide substrates for receptor-mediated endocytosis by macrophages. Proc Nat Acad Sci U S A 1981; 12: 72947298.
  • 28
    Hoppe CA, Lee YC. The binding and processing of mannose-bovine serum albumin derivatives by rabbit alveolar macrophages. Effect of sugar density. J Biol Chem 1983; 258: 1419314199.
  • 29
    Hoppe CA, Lee YC. Accumulation of a nondegradable mannose ligand within rabbit alveolar macrophages. Receptor reutilization is independent of ligand degradation. Biochemistry 1984; 23: 17231730.
  • 30
    Maynard Y, Baenziger JU. Oligosaccharide specific endocytosis by isolated rat hepatic reticuloendothelial cells. J Biol Chem 1981; 256: 80638068.
  • 31
    Sallusto F, Cella M, Danieli C, Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med 1995; 182: 389400.
  • 32
    Muchmore AV, Sathyamoorthy N, Decker J, Sherblom AP. Evidence that specific high-mannose oligosaccharides can directly inhibit antigen-driven T-cell responses. J Leukoc Biol 1990; 48: 457464.
  • 33
    Taylor ME, Conary JT, Lennartz MR, Stahl PD, Drickamer K. Primary structure of the mannose receptor contains multiple motifs resembling carbohydrate-recognition domains. J Biol Chem 1990; 265: 1215612162.
  • 34
    Taylor ME, Bezouska K, Drickamer K. Contribution to ligand binding by multiple carbohydrate-recognition domains in the macrophage mannose receptor. J Biol Chem 1992; 267: 17191726.
  • 35
    Taylor ME, Drickamer K. Structural requirements for high affinity binding of complex ligands by the macrophage mannose receptor. J Biol Chem 1993; 268: 399404.
  • 36
    Pâques EP, Just M, Reiner G, Römisch J. Pharmacological and pharmacokinetic properties of a deglycosylated mutant of the tissue-type plasminogen activator expressed in CHO cells. Fibrinolysis 1992; 6: 125130.
  • 37
    Chakraborty P, Das PK. Role of mannose/N-acetylglucosamine receptors in blood clearance and cellular attachment of Leishmania Donovani. Mol Biochem Parasitol 1988; 28: 5562.
  • 38
    Kahn S, Wleklinski M, Aruffo A, Farr A, Coder D, Kahn M. Trypanosoma cruzi amastigote adhesion to macrophages is facilitated by the mannose receptor. J Exp Med 1995; 182: 12431258.
  • 39
    Schlesinger LS, Hull SR, Kaufman TM. Binding of the terminal mannosyl units of lipoarabinomannan from a virulent strain of Mycobacterium tuberculosis to human macrophages. J Immunol 1994; 152: 40704079.
  • 40
    Chakraborty P, Bhanduri AN, Das PK. Sugar receptor mediated drug delivery to macrophages in the therapy of experimental visceral leishmaniasis. Biochem Biophys Res Commun 1990; 166: 404410.
  • 41
    Ferkol T, Perales JC, Mularo F, Hanson RW. Receptor-mediated gene transfer into macrophages. Proc Nat Acad Sci U S A 1996; 93: 101105.